4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Clearmind Medicine Inc. (CMND) operates in the Biotechnology industry and is headquartered in Vancouver, Canada. Its market capitalization is roughly $3 million. In the fiscal year ended 2025-10-31, CMND reported $0M in revenue and ($4M) in net income.
Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems.
Interactive charts & full statements →
| Income statement | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($6M) | ($6M) | ($6M) | ($6M) | — |
| Net Income | ($4M) | ($5M) | ($9M) | ($7M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($2M) | ($4M) | ($2M) | ($1M) | ($1M) | — |
| Net Income | ($2M) | ($4M) | ($1M) | ($1M) | ($1M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | — | $0M | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Total Assets | $6M | $7M | $6M | $1M | — |
| Total Liabilities | $5M | $4M | $5M | $2M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CMND viewer.
About TickerBase · Data methodology & sources